RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (RLMD)

Q: What does CUSIP 75955J402 represent in this 13F holders report?

CUSIP 75955J402 is the security identifier for RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q1 2020?

43 institutional investors reported RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share for Q1 2020. Use the holders table for investor-level position and value details.

CUSIP: 75955J402

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 104,915,374
Total 13F shares: 9,357,083
Share change: +2,819,527
Total reported value: $319,169,853
Price per share: $34.11
Number of holders: 43
Value change: +$94,707,648
Number of buys: 26
Number of sells: 15

Quarterly Holders Quick Answers

What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 75955J402:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
TANG CAPITAL MANAGEMENT LLC	13F	Company	1.2%	1,300,000	$50,700,000	—	31 Dec 2019	13F
VHCP Management III, LLC	13F	Company	0.73%	767,938	$29,950,000	—	31 Dec 2019	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.73%	761,666	$29,705,000	—	31 Dec 2019	13F
RTW INVESTMENTS, LP	13F	Company	0.63%	664,484	$25,915,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	0.54%	569,753	$22,220,000	—	31 Dec 2019	13F
PARSONS CAPITAL MANAGEMENT INC/RI	13F	Company	0.35%	366,933	$14,310,000	—	31 Dec 2019	13F
Boxer Capital, LLC	13F	Company	0.29%	300,000	$11,700,000	—	31 Dec 2019	13F
TIEDEMANN ADVISORS, LLC	13F	Company	0.27%	282,592	$11,021,000	—	31 Dec 2019	13F
Invesco Ltd.	13F	Company	0.26%	269,237	$10,500,000	—	31 Dec 2019	13F
FRANKLIN RESOURCES INC	13F	Company	0.21%	225,000	$8,775,000	—	31 Dec 2019	13F
Broadfin Capital, LLC	13F	Company	0.21%	220,724	$8,608,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	0.14%	143,113	$5,582,000	—	31 Dec 2019	13F
Point72 Asset Management, L.P.	13F	Company	0.13%	136,900	$5,339,000	—	31 Dec 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.12%	129,461	$5,049,000	—	31 Dec 2019	13F
VHCP Management II, LLC	13F	Company	0.11%	114,876	$4,480,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.1%	102,614	$4,002,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.09%	97,108	$3,787,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.08%	80,166	$3,126,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.05%	49,187	$1,919,000	—	31 Dec 2019	13F
MEYER HANDELMAN CO	13F	Company	0.03%	30,378	$1,185,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.02%	24,281	$947,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	23,201	$905,000	—	31 Dec 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.02%	17,599	$686,000	—	31 Dec 2019	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.01%	13,000	$507,000	—	31 Dec 2019	13F
World Investment Advisors	13F	Company	0.01%	13,000	$507,000	—	31 Dec 2019	13F
ExodusPoint Capital Management, LP	13F	Company	0.01%	11,755	$458,000	—	31 Dec 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	10,159	$396,000	—	31 Dec 2019	13F
Avidity Partners Management LP	13F	Company	0.01%	10,000	$390,000	—	31 Dec 2019	13F
Squarepoint Ops LLC	13F	Company	0.01%	8,918	$348,000	—	31 Dec 2019	13F
CHARTWELL INVESTMENT PARTNERS, LLC	13F	Company	0.01%	8,780	$342,000	—	31 Dec 2019	13F
MYDA Advisors LLC	13F	Company	0.01%	7,000	$273,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.01%	6,748	$263,000	—	31 Dec 2019	13F
TD ASSET MANAGEMENT INC	13F	Company	0.01%	6,493	$253,000	—	31 Dec 2019	13F
BROWN BROTHERS HARRIMAN & CO	13F	Company	0.01%	6,000	$234,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.01%	5,413	$211,000	—	31 Dec 2019	13F
UBS Group AG	13F	Company	0%	4,257	$166,000	—	31 Dec 2019	13F
Tortoise Investment Management, LLC	13F	Company	0%	2,900	$113,000	—	31 Dec 2019	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	2,143	$84,000	—	31 Dec 2019	13F
SIMPLEX TRADING, LLC	13F	Company	0%	2,140	$83,000	—	31 Dec 2019	13F
CITIGROUP INC	13F	Company	0%	936	$37,000	—	31 Dec 2019	13F
NEXT Financial Group, Inc	13F	Company	0%	306	$12,000	—	31 Dec 2019	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0%	175	$7,000	—	31 Dec 2019	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0%	121	$5,000	—	31 Dec 2019	13F
ROYAL BANK OF CANADA	13F	Company	0%	36	$1,000	—	31 Dec 2019	13F
Glen Eagle Advisors, LLC	13F	Company	0%	25	$975	—	31 Dec 2019	13F

Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (RLMD) as of Q1 2020

As of 31 Mar 2020, RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (RLMD) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,357,083 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., TANG CAPITAL MANAGEMENT LLC, Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, VR Adviser, LLC, VANGUARD GROUP INC, BlackRock Inc., PARSONS CAPITAL MANAGEMENT INC/RI, CITADEL ADVISORS LLC, and BOXER CAPITAL, LLC. This page lists 43 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

Q1 2020 holders

Holder diff

-1

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.